• Bayer reaches settlement to resolve Xarelto™ litigation worldpharmanews
    March 26, 2019
    More than five years after the Xarelto™ litigation began, and with Bayer and Janssen Pharmaceuticals prevailing in all six cases that went to trial, the companies have reached an agreement in principle to settle in the amount of 775 million U.S. dollars.
PharmaSources Customer Service